AIDS Treatments: Discounts Here to Stay

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-10-01-2001
Volume 0
Issue 0

Rio de Janeiro-The Brazilian health ministry will use its $35 million a year in savings on Roche’s newly discounted AIDS therapy to fund a program aimed at providing non-AIDS medicines to low-income families.

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Related Content